Automatic Web Traffic Generator

Arrowhead Pharmaceuticals - Finally, Another Buying Opportunity

Latest downturn in Arrowhead stock is unjustified as it is not based on any specific news item. Upcoming earnings and cash concerns are what investors should be focused on short-term. Look for a ... read more

Arrowhead Pharmaceuticals Inc (ARWR) Q1 2019 Earnings Conference Call Transcript

welcome to the Arrowhead Pharmaceuticals conference call. Throughout today's recorded presentation, all participants will be in a listen-only mode. After the presentation, there will be an opportunity ... read more

Amgen strikes $674M cardiovascular RNAi pact with Arrowhead

Amgen ($AMGN) has handed over an initial $56.5 million and committed to up to $617 million more to buy into Arrowhead Pharmaceuticals’ ($ARWR ... and an exclusive option to pick up the rights to ... read more

Arrowhead Pharmaceuticals: Looks To Be Time For Another Breakout

These partnerships should help to significantly de-risk the company and its candidates as these partners are buying into ... SEQUOIA study to finally finish. Arrowhead Pharmaceuticals also was ... read more

Juvenile Diabetes Market: Global Analysis and Opportunity and Forecast by 2024: Sanofi, Novo Nordisk, AstraZeneca, Biodel

Juvenile Diabetes Market explores effective study on varied sections of Industry like opportunities, size ... Eli Lilly and Company (United States), Bayer Pharmaceuticals (Germany), Sanofi (France), ... read more

Chiefs vs. Patriots: game and score predictions

The last time the Patriots came to Arrowhead ... This won’t be Mahomes’ last opportunity to play in the AFC championship game. It won’t be his last game of this season, either. I’m buying stock in the ... read more

Is Corbus Pharmaceuticals a Buy Now?

It's been a little over a decade since Corbus Pharmaceuticals ... Finally, there's a chance that lenabasum can become a new treatment option for people with systemic lupus erythematosus, another ... read more

2 Top Stocks to Watch at ASCO 2019

Emily, finally ... drugs by the end of 2020 that work similarly, and it's all going to come down to, am I going to use this drug because the data was so much better for this one, or this one. Jones: ... read more

Here are the bills Gov. Hogan still might veto — and why he should sign them instead

President Trump has talked a lot about lowering the cost of prescription drugs, but there’s reason to doubt ... will operate from a pro- or anti-gun agenda. Finally, Governor Hogan has the opportunity ... read more

Mellinger Minutes: Here comes the first AFC Championship Game to be played in KC

By The bar is low but the most memorable win at Arrowhead Stadium in the 21st century might have ... If the Patriots block a punt, then Patrick Mahomes needs another Daddy’s Home touchdown drive. If ... read more

3 Top Biotech Stocks to Buy Right Now

Armed with this insight, we asked three Motley Fool contributors which biotech stocks they think are worth buying right now. They picked Gilead Sciences (NASDAQ: GILD), Alexion Pharmaceuticals ... the ... read more

Is Corbus Pharmaceuticals a Buy?

Check out the latest Corbus Pharmaceuticals ... is another rare and serious autoimmune disease that's characterized by skin and muscle inflammation and has a 30% five-year mortality rate. This ... read more